NAC syrup for babies with bile duct disease
Treatments studied
Part of Digestive system, Genetic & congenital clinical trials.
This study tests whether a medicine called NAC (an antioxidant that helps protect the liver) can be safely given to infants with biliary atresia by mouth. It aims to see if babies can tolerate it, which might eventually help their liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be between 4 and 9 months old.
- Biliary atresia must be confirmed (diagnosed) by a special surgery or procedure.
- Your baby must be able to eat and take medicine by mouth, without needing a feeding tube.
- Your baby must be able to stay in the hospital for at least 4 days.
- A parent or guardian must agree to the study after understanding what it involves.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special nutrition plan helps babies with biliary atresia recover better after Kasai surgery. It is for infants under 3 months old who are ready for surgery.
This study follows babies under 6 months old who have early signs of liver disease (cholestasis) to better understand what causes it and how it progresses. Researchers will collect medical information over time to improve diagnosis and treatment.
This study enrolls children and young adults with biliary atresia (a condition where bile can’t flow properly from the liver) to learn from their care and outcomes over scheduled visits. It may help researchers understand the disease better and improve future treatment.
This study looks at babies with possible liver problems (cholestasis) who have been referred to the Birmingham Liver Unit. Researchers want to collect information from nappy (diaper) samples to better understand these conditions.
This trial tests whether a special nutritional support formula rich in medium-chain fats can help infants with biliary atresia after the Kasai procedure. It may support feeding and liver recovery during the early months after surgery.
This trial is studying children who have biliary atresia, a serious liver problem, including some who also have tetralogy of Fallot (a congenital heart condition). It also includes healthy children for comparison, and may help researchers understand the illness and treatments better.
Hear when a new Biliary Atresia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.